4188 — Mitsubishi Chemical Balance Sheet
0.000.00%
Annual balance sheet for Mitsubishi Chemical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 296,874 | 371,693 | 377,728 | 392,247 | 621,608 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 825,996 | 808,787 | 852,353 | 764,814 | 671,912 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,986,116 | 2,149,618 | 2,191,636 | 2,061,560 | 2,095,247 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,899,695 | 1,907,898 | 2,043,330 | 2,004,447 | 2,096,630 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,573,871 | 5,774,348 | 6,104,513 | 5,894,619 | 5,876,609 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,419,293 | 1,663,830 | 1,724,912 | 1,500,158 | 1,400,901 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 4,115,794 | 4,209,650 | 4,341,066 | 4,154,049 | 4,114,934 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,458,077 | 1,564,698 | 1,763,447 | 1,740,570 | 1,761,675 |
| Total Liabilities & Shareholders' Equity | 5,573,871 | 5,774,348 | 6,104,513 | 5,894,619 | 5,876,609 |
| Total Common Shares Outstanding |